Drug Utilization Patterns and WHO Prescribing Indicators Among Hypertensive Outpatients at Karnali Academy of Health Sciences, Nepal: A Cross-Sectional Study. [PDF]
ABSTRACT Hypertension is one of the most prevalent non‐communicable diseases (NCDs) worldwide. This descriptive cross‐sectional study evaluated drug utilization patterns and WHO core prescribing indicators among hypertensive patients attending the Outpatient Department of Karnali Academy of Health Sciences (KAHS), Jumla.
Aryal B +3 more
europepmc +2 more sources
Adverse Oral Mucosal Reaction to Sublingual Captopril: A Case Report With Exploratory Insights Into AI-Assisted Clinical Reasoning. [PDF]
Júnior ARG +6 more
europepmc +1 more source
Severe angioedema following dupilumab therapy for bullous pemphigoid. [PDF]
Mummareddy H, Han S, Shroyer W.
europepmc +1 more source
Risk factors for drug-related impaired gastric emptying: a pharmacovigilance analysis of the FDA adverse event reporting system. [PDF]
Chen JH +5 more
europepmc +1 more source
Serine encodes drug selectivity in human OAT1. [PDF]
Dai Y, Lee CH.
europepmc +1 more source
Stability of Olmesartan Medoxomil Tablets in Unit-Dose Packaging With Metformin Hydrochloride Tablets. [PDF]
Ohashi R +8 more
europepmc +1 more source
Single-Pill Combination Olmesartan/Amlodipine/Hydrochlorothiazide Safety and Effectiveness in Older Patients with Hypertension: Pooled Analysis of Post-Approval Observational Studies. [PDF]
Kim HJ, Kim HM, Kim DH.
europepmc +1 more source
Drug-associated inflammatory bowel disease: a real-world pharmacovigilance study using the FAERS and JADER databases. [PDF]
Ying Y +8 more
europepmc +1 more source
Chronic plateau exposure attenuates antihypertensive efficacy in highlanders: insights from the OMAN trial. [PDF]
Zuo X +9 more
europepmc +1 more source
A Retrospective Analysis of Human Angiotensin II Receptor Blockers (ARB) Pharmacokinetics, Dosages and C<sub>max</sub> Values for the Experimental Modelling of Pleiotropic and Supratherapeutic Activities. [PDF]
Evans A, Bernatchez P.
europepmc +1 more source

